Kate C. Tatham

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

The evolution of mortality from sepsis in patients with cancer: A systematic review and meta-analysis.

The evolution of mortality from sepsis in patients with cancer: A systematic review and meta-analysis.

Journal: Journal of the Intensive Care Society
Published: September 30, 2025

Survival of Patients with Solid Tumours and Sepsis Admitted to Intensive Care in a Tertiary Oncology Centre: A Retrospective Analysis.

Survival of Patients with Solid Tumours and Sepsis Admitted to Intensive Care in a Tertiary Oncology Centre: A Retrospective Analysis.

Journal: Journal of intensive care medicine
Published: January 28, 2025

Patients with cancer and sepsis trials: an unfair representation?

Patients with cancer and sepsis trials: an unfair representation?

Journal: Clinical medicine (London, England)
Published: December 05, 2023

AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells.

AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate Cells.

Journal: Cellular and molecular gastroenterology and hepatology
Published: August 25, 2022

Sepsis biomarkers and diagnostic tools with a focus on machine learning.

Sepsis biomarkers and diagnostic tools with a focus on machine learning.

Journal: EBioMedicine
Published: August 19, 2022

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.

Journal: Cell reports. Medicine
Published: June 06, 2022

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.

Journal: Cancer cell
Published: March 30, 2022

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.

Journal: Lancet (London, England)
Published: December 29, 2021

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.

Journal: Nature cancer
Published: December 24, 2021

Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Journal: Research square
Published: September 28, 2021

The REMDACTA trial: do interleukin receptor antagonists provide additional benefit in COVID-19?

The REMDACTA trial: do interleukin receptor antagonists provide additional benefit in COVID-19?

Journal: Intensive care medicine
Published: September 16, 2021

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Journal: Nature cancer
Published: August 23, 2021
Showing 1-12 of 27

Last Updated: 09/26/2026